Anaplastic Thyroid Cancer: A Review of Epidemiology, Pathogenesis, and Treatment

The Feasibility Study of Docetaxel in Patients with Anaplastic Thyroid Cancer

(2010) K. Kawada et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

High Efficacy of Concomitant Treatment of Undifferentiated (Anaplastic) Thyroid Cancer with Radiation and Docetaxel

(2010) Marlene Troch et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Inhibition of Tumor Angiogenesis by the Matrix Metalloproteinase-Activated Anthrax Lethal Toxin in an Orthotopic Model of Anaplastic Thyroid Carcinoma

(2010) R. W. Alfano et al.   MOLECULAR CANCER THERAPEUTICS

Thyroid Cancer Incidence and Survival in the National Cancer Institute Surveillance, Epidemiology, and End Results Race/Ethnicity Groups

(2010) Guo-Pei Yu et al.   THYROID

Lower Incidence of Anaplastic Carcinoma After Higher Iodination of Salt in Slovenia

(2010) Nikola Besic et al.   THYROID

Epidemiology, clinical presentation, treatment and prognosis of a regional series of 26 anaplastic thyroid carcinomas (ATC). Comparison with the literature

(2009) B. Roche et al.   ANNALES D ENDOCRINOLOGIE

Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy

(2009) Aarti Bhatia et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Multimodality treatment for anaplastic thyroid carcinoma – Treatment outcome in 75 patients

(2009) Annemarie T. Swaak-Kragten et al.   RADIOTHERAPY AND ONCOLOGY

A Phase II Trial of Fosbretabulin in Advanced Anaplastic Thyroid Carcinoma and Correlation of Baseline Serum-Soluble Intracellular Adhesion Molecule-1 with Outcome

(2009) Colin J. Mooney et al.   THYROID

Induction Chemotherapy with Weekly Paclitaxel Administration for Anaplastic Thyroid Carcinoma

(2009) Takuya Higashiyama et al.   THYROID

Surgery and Radiotherapy Improves Survival in Patients With Anaplastic Thyroid Carcinoma

(2008) Jergin Chen et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Treatment Outcomes in Anaplastic Thyroid Carcinoma: Survival Improvement in Young Patients With Localized Disease Treated by Combination of Surgery and Radiotherapy

(2008) Thomas Yau et al.   ANNALS OF SURGICAL ONCOLOGY

Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

(2008) Ezra E.W. Cohen et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial of Sorafenib in Advanced Thyroid Cancer

(2008) Vandana Gupta-Abramson et al.   JOURNAL OF CLINICAL ONCOLOGY